27. März 2025 – On 20^th March 2025, Galderma (SIX: GALD), the pure-play dermatology category leader present in approximately 90 countries, has successfully issued (i) an inaugural EUR 500 million guaranteed bond, with a 5-year maturity and a 3.5% fixed-rate annual coupon, (ii) a CHF 190 million guaranteed bond, with a 4-year maturity and a 1.4025% fixed-rate annual coupon and (ii) a CHF 245 million guaranteed bond, with a 8-year maturity and a 1.8098% fixed-rate annual coupon. The bonds will all be listed on the SIX Swiss Exchange. The net proceeds of the transactions will be used for the partial refinancing of Galderma’s existing Bank Term Loan issued at its initial public offering (IPO) as well as for general corporate purposes.

The EUR transaction was led by BNP Paribas, J.P. Morgan, Mizuho, and Santander as active bookrunners, while the CHF transaction was led by BNP Paribas and UBS as joint lead managers.

Walder Wyss advised the banking syndicate on both the EUR and CHF transactions. The team was led by David Borer (Partner, Capital Markets) and included Laura Tarenzi (Senior Associate, Capital Markets), Ganna Schneuwly (Transaction Manager, Capital Markets) and Maurus Winzap (Partner, Tax).